Page last updated: 2024-10-24

chlorambucil and Epstein-Barr Virus Infections

chlorambucil has been researched along with Epstein-Barr Virus Infections in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Epstein-Barr Virus Infections: Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murray, PG1
Billingham, LJ1
Hassan, HT1
Flavell, JR1
Nelson, PN1
Scott, K1
Reynolds, G1
Constandinou, CM1
Kerr, DJ1
Devey, EC1
Crocker, J1
Young, LS1

Trials

1 trial available for chlorambucil and Epstein-Barr Virus Infections

ArticleYear
Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease.
    Blood, 1999, Jul-15, Volume: 94, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free Survival; England; Epstei

1999